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Abstract
Objective—HIV-1 escape from cytotoxic T-lymphocytes (CTL) results in the accumulation of 
HLA-associated mutations in the viral genome. To understand the contribution of early escape to 
disease progression, this study investigated the evolution and pathogenic implications of CTL 
escape in a cohort followed from infection for five years.
Methods—Viral loads and CD4+ counts were monitored in 78 subtype C infected individuals 
from onset of infection until CD4+ decline to <350 cells/μl or five years post-infection. The gag 
gene was sequenced and HLA-associated changes between enrolment and 12 months post-
infection were mapped.
Results—HLA-associated escape mutations were identified in 48 (62%) of the participants and 
were associated with CD4+ decline to <350 copies/ml (p=0.05). Escape mutations in variable Gag 
proteins (p17 and p7p6) had a greater impact on disease progression than escape in more 
conserved regions (p24) (p=0.03). The association between HLA-associated escape mutations and 
CD4+ decline was independent of protective HLA allele (B*57, B*58:01, B*81) expression.
Conclusion—The high frequency of escape contributed to rapid disease progression in this 
cohort. While HLA-adaption in both conserved and variable Gag domains in the first year of 
infection was detrimental to long term clinical outcome, escape in variable domains had greater 
impact.
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Introduction
HIV-1 subtype C-infected women in South Africa generally have rapid disease progression 
with more than 31 % having CD4+ decline to <350 cell/μl in the first year of infection [1]. 
Under the current WHO treatment guidelines (CD4+ count of <500 cell/μl), about 70% of 
these women would need to go on therapy in the first year of infection [1]. Cytotoxic T 
lymphocyte (CTL) responses, in particular Gag-targeted responses, are known to contribute 
to viral control in HIV-1 infections and drive the virus to escape through mutations [2]. The 
detrimental impact of immune evasion on pathogenesis can be alleviated in certain cases 
where escape has a fitness cost on the virus [3-7]. While is it known that clinical parameters 
in early infection are predictive of subsequent disease progression [1], and it is well 
established that specific escape mutations restricted by protective HLA-alleles [5, 7-11] can 
have a beneficial impact, less is understood at a population level how immune escape in 
early infection impacts long term clinical outcome.
Protective HLA alleles, which generally target conserved epitopes, drive the evolution of 
CTL escape mutations which can attenuate viral replication resulting in slower disease 
progression [3, 5, 10, 12]. An HLA-independent study of 17 individuals, monitored from 
acute infection, found CTL escape occurred in all individuals within the first 50 days of 
infection [13]. The likelihood of escape was determined by a combination of the most 
dominant CTL response in an individual, together with the entropy of the target [13]. In this 
cohort of 17, escape in Gag was demonstrated in approximately 30% (n=5) of individuals 
[13].
Several large cohort studies have demonstrated that CTL escape can be predicted based on 
the HLA alleles expressed by the host [14-19]. Furthermore, there is an inverse correlation 
between the potential breadth of HLA-mediated anti-Gag selection pressure, identified as the 
total number of potential HLA-associated sites, and viral loads [19, 20]. These studies have 
largely been done in chronic infection, and while it is known that events in the acute/early 
phase of infection are important predictors of disease progression [21], and there is limited 
information on the role of evolving HLA-associated polymorphisms during this critical 
period and their long-term impact on disease.
In this paper, we report on a study of 78 individuals recruited within the first three months of 
infection, and followed for at least five years, or until CD4+ decline to <350 cells/μl. Taking 
advantage of well documented databases that have mapped HLA-associated polymorphisms 
in subtype C infection, we identified putative CTL escape mutations across the Gag protein 
in the first year of infection and investigated the impact on CD4+ decline. The information 
reported here augments our understanding of mechanisms associated with rapid disease 
progression in this cohort. Understanding the extent of escape in early infection is also 
important to HIV-1 cure studies as it has been shown that these escape variants get archived 
Chopera et al. Page 2

















Participants in this study (n=78) were HIV-1 infected women from the CAPRISA 002 acute 
infection cohort [23] and the placebo arm of the CAPRISA 004 1% tenofovir gel 
microbicide trial [24]. We excluded participants from the treatment arm as there are ongoing 
studies to determine whether the 1% tenofovir gel resulted in selection of viruses with 
altered characteristics. We also excluded individuals who were dually-infected (co- and 
super-infected) as well as those who were non-subtype C infected. The CAPRISA 002 Acute 
Infection study was reviewed and approved by the research ethics committees of the 
University of KwaZulu-Natal (E013/04) and the University of Cape Town (025/2004). 
Written consent was obtained from all participants.
RNA isolation, RT-PCR and viral sequencing
The gag region was amplified and sequenced from plasma samples collected at enrolment 
(earliest available sample post-infection) and 12 months post-infection by nested RT-PCR as 
described previously [25]. RNA isolated from plasma samples using the Magna-Pure 
Compact Nucleic Acid Extractor (Roche) was reverse transcribed using the Invitrogen 
Thermoscript Reverse transcription kit (Invitrogen) and the primer Gag D reverse (5′-AAT 
TCC TCC TAT CAT TTT TGG-3′; HXB2 position 2382-2402). Limiting dilution nested 
PCR was carried out by serial end-point dilution of the cDNA [26]. The first round PCR 
primers for amplification were Gag D forward (5′-TCT CTA GCA GTG GCG CCC G-3′; 
HXB position 626-644) and Gag D reverse. The second round PCR primers were Gag A 
forward (5′-CTC TCG ACG CAG GAC TCG GCT T-3′; HXB2 position 683-704) and Gag 
C reverse (5′-TCT TCT AAT ACT GTA TCA TCT GC-3′; HXB2 position 2334-2356). 
PCR products were sequenced using an ABI PRISM dye terminator cycle-sequencing kit 
(Applied Biosysytems) and the primers Gag A forward, Gag A reverse (5′-ACA TGG GTA 
TCA CTT CTG GGC T-3′; HXB2 position 1282-1303), Gag B forward (5′-CCA TAT CAC 
CTA GAA CTT TGA AT-3′; HXB2 position 1226-1246), Gag B reverse (5′-CTC CCT 
GAC ATG CTG TCA TCA T-3′; HXB2 position 1825-1846), Gag C forward (5′-CCT TGT 
TGG TCC AAA ATG CGA-3′; HXB2 position 1748-1768) and Gag C reverse. Sequences 
were assembled using ChromasPro (www.technelysium.com.au/chromas.html).
For participants included in this study, the gag sequences from the enrolment and 12 months 
post-infection visits from each participant grouped together on a phylogenetic tree (data not 
shown).
HLA typing
High resolution (four digit) HLA typing was performed on all participants. DNA was 
extracted from either PBMCs or granulocytes using the Pel-Freez DNA Isolation kit (Pel-
Freez). HLA-A, -B and -C typing was performed by sequencing of exons 2, 3 and 4 using 
Atria HLA-AlleleSeqr kits (Abbott) or HLA-SBTexcellerator kits (Qiagen) and Assign-SBT 
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v3.5 software (Conexio Genomics). Any ambiguities resulting from either polymorphisms 
outside the sequenced exons or identical heterozygote combinations were resolved using 
sequence-specific primers, or resolved statistically using the algorithm developed for this 
purpose [27].
Identification of CTL escape
HLA-associated CTL escape was determined by comparison of HLA-associated sites, 
derived from a large subtype C chronic infection dataset [16], between enrolment and 12 
months Gag amino acid sequences according to each participant's HLA genotype. The list of 
HLA-associated polymorphisms resulted from analysis of 2,126 chronically HIV-1 subtype 
C-infected anti-retroviral-naïve individuals from Southern Africa and found 301 
polymorphisms in 90 epitopes [16]. Escape was defined as a change towards an HLA-
adapted amino acid or away from a non-adapted amino acid [16]. In addition, mutations at 
HLA-associated sites which were neither going towards or away from adapted or non-
adapted residues were also classified as escape. Plasma viral loads and CD4+ counts at 12 
months post-infection were calculated by taking the mean of three time-points closest to 12 
months post-infection.
Statistical analyses
All statistical analyses were carried out in Graphpad Prism 5.0 (GraphPad Software, Inc.).
Results
A total of 78 HIV-1 subtype C infected women were studied over a five year period, or until 
CD4+ decline to <350 cells/μl. The median (IQR) time post-infection for the earliest 
samples was 40 (26-54) days post-infection. At 12 months post-infection (set-point), the 
median log plasma viral load and CD4+ count were 4.20 copies/ml and 432 cells/μl, 
respectively.
Escape was identified as changes in Gag amino acids sites between enrolment and twelve 
months post-infection at positions that have previously been shown to positively correlate 
with the participants HLA-alleles [16]. This list of HLA-associated polymorphism was 
derived from a chronic database, and it likely reflects both early and late escaping epitopes. 
We thus evaluated whether there was an association between the observed mutations and the 
total number expected based on the participants' HLA genotype. We found a significant 
association between the observed number of HLA-associated escape mutations and the 
HLA-associated polymorphisms over 12 months post-infection (Spearman r=0.3; p=0.03) 
(Figure 1A), supporting the use of this list for evaluation sequences from early infection.
Potential CTL breadth in p24 associated with 12 months viral load set-point
To determine if there was a relationship between the total potential CTL pressure that an 
individual exerts on the virus, and disease outcome, we calculated the total number of 
potential HLA-associated sites restricted by each participants HLA allele. We found no 
association between number of potential HLA-associated sites and either viral load or CD4+ 
count for the entire Gag region or each of the Gag regions (p17, p24 and p7p6) (data not 
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shown). However, there was a strong trend towards a negative association between the 
number of potential HLA-associated sites in p24 Gag and plasma viral load (Spearman 
r=-0.2; p=0.07) (Figure 1B). This supports previous findings from acute and chronic 
infection [12, 28-30] and suggests that the CTL pressure on the conserved p24 Gag region 
contributed to early viral control.
Higher frequency of escape in more variable p17 Gag
We then investigated actual escape across different Gag proteins (p17, p24 and p7p6). We 
identified HLA-associated escape mutations in the first year of infection in 48 (62%) study 
participants, with escape occurring in 1-5 sites per participant (Figure 1C). HLA-associated 
mutations occurred most frequently in p17 in 33 (42%) individuals, followed by escape in 
p24 in 22 (28%) individuals, and lastly in p7p6 in 14 (18%) individuals (Figure 1C). 
Twenty-three percent of the study participants harboured viruses that developed HLA-
associated mutations only in p17, 16% only in p24, and 1% only in p7p6 (Supplementary 
Figure 1). Normalisation of the number of HLA-associated mutations relative to the protein 
size further accentuated the differences in frequency between proteins with HLA-associated 
escape mutations per amino acid significantly higher in p17compared to p24 (p=0.004) and 
p7p6 (p<0.0001) (Figure 1D).
Early HLA-associated escape mutations predict CD4+ decline to < 350 μl/ml
CTL escape in p24 has previously been reported to be beneficial in terms of lowering viral 
loads in early infection [5, 7]. We were interested in evaluating the relative impact of escape 
across all Gag proteins. We first compared the time to CD4+ counts of <350 cells/μl in the 
first five years of infection for participants whose infecting viruses developed CTL escape 
and those where escape was not observed. The time to CD4+ decline <350 cells/μl was 
significantly shorter for participants whose infecting viruses developed CTL escape (p=0.05, 
log rank test) (Figure 2A). As escape in p24 tends to be associated with reduced viral load 
[5-7], we stratified the HLA-associated escape mutations into p24 escape and p17/p7p6 
escape (individuals where HLA-associated escape mutations were observed in both p24 and 
variable regions were classified as p24 escape). Individuals whose viruses developed HLA-
associated escape mutations in variable proteins (p17 and p7p6) progressed more rapidly to 
CD4+ decline to <350 cells/μl over 5 years, compared to those whose viruses developed p24 
HLA-associated escape mutations [the order of progression; no escape > p24 escape > p17/
p7p6 escape (p=0.03, log-rank test)] (Figure 2B). Interestingly, of the 22 participants whose 
infecting viruses developed HLA-associated escape mutations in p24, only 11 (41%) had 
mutations at sites previously described to have a fitness cost to virus replication (HXB2 
positions 146[31], 182[32], and 242[33]) (Supplementary Table 1). This suggests that while 
CTL escape is associated with rapid CD4+ decline, escape in escape in the variable p17 and 
p7p6 proteins was more detrimental to disease progression than escape in the conserved p24 
region.
HLA-associated escape in early infection is independent of plasma viral load
As both viral load and CD4+ count are predictors of disease progression, viral load is a 
potential confounder if the emergence of CTL escape mutations was driven by high viral 
loads. To interrogate this, we compared the plasma viral loads at 12 months post-infection 
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between participants whose infecting viruses developed HLA-associated escape mutations 
(escape group) and those who did not (no-escape group). We found no differences in viral 
loads between the two groups (p=0.4) (data not shown). We also compared viral loads 
between the escape and no-escape groups at enrolment, three months and six months post-
infection and found no difference (p=0.3, p=0.6 and p=0.5, respectively) (data not shown). 
Repeating these analyses after removal of individuals with protective HLA alleles (HLA 
B*57, B*58:01 and B*81; n=18) also showed no significant difference (p>0.5) (data not 
shown). This suggests that the emergence of HLA-associated escape mutations in early 
infection was independent of viral load.
Impact of HLA-associated escape mutations on CD4+ decline is independent of protective 
HLA alleles
As some HLA alleles are known to be protective and associated with slower disease 
progression, we investigated whether there was enrichment of protective HLA alleles (HLA 
B*57, B*58:01 and B*81) in either group (escape and no escape). There was no significant 
difference in HLA alleles between the two groups [12/48 (25%) vs. 6/30 (20%), 
respectively; p=0.5; Fisher's exact test] (Figure 3A), and we found that protective HLA 
alleles were associated with a slower decline to CD4+ counts of <350 cells/μl (p=0.02) 
(Figure 3B). Assessment of CD4+ decline after excluding individuals with protective HLA 
alleles showed that individuals whose viruses developed HLA-associated escape mutations 
had rapid CD4+ decline (p=0.05) (Figure 3C). We also observed that individuals whose 
viruses developed HLA-associated escape mutations in variable proteins (p17 and p7p6) 
progressed more rapidly to CD4+ decline to <350 cells/μl over 5 years, compared to those 
whose viruses developed p24 HLA-associated escape mutations [the order of progression; 
no escape > p24 escape > p17/p7p6 escape (p=0.05, log-rank test)] (Figure 3D).These 
results suggest that the effect of HLA-associated escape mutations on CD4+ decline is 
independent of protective HLA alleles.
Discussion
To understand factors contributing to rapid disease progression observed in a subtype C 
cohort in South Africa [1], we examined the impact of early CTL escape in Gag on disease 
progression. We detected a high frequency of HLA-associated escape mutations (48% of the 
study participants) which occurred predominantly in the p17 region (42% of participants). 
The development of HLA-associated escape mutations in the first year of infection was 
associated with a more rapid decline to CD4+ count of <350 cells/μl, and the effect of 
escape was more pronounced for mutations occurring in the variable Gag proteins.
The breadth of CTL responses as well as targeting of conserved regions has been shown to 
be associated with viral control [12, 28, 29]. We reasoned that the number of HLA-
associated escape sites for each individual is a measure of the potential CTL pressure that 
the individual exerts on the virus. We found a trend towards a negative association between 
the total potential number of HLA-associated escape sites and plasma viral load at 12 
months post-infection (Spearman r=-0.2; p=0.07) for p24 Gag. This underscores the 
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importance of CTL responses targeting the functionally and structurally conserved p24 
region and supports previous findings from chronic subtype B infections [20].
Previous studies have reported specific immune escape mutations in p24 Gag that are 
associated with partial attenuation of viral replicative fitness and slower disease progression 
[5, 7, 8]. In this study participants in whom HLA-associated escape mutations developed in 
the first year of infection progressed faster to CD4+ count <350 cells/μl compared to those 
where HLA-associated escape mutations were not detected (p=0.05). However, individuals 
whose viruses escaped in the more variable p17/p7p6 regions progressed faster to CD4+ 
count <350 cells/μl compared to those where HLA-associated escape mutations were 
observed in the more conserved p24. These results suggest that while overall CTL escape is 
detrimental to the host, escape in the variable regions of the virus (p17 and p7p6) is 
associated with a more rapid CD4+ decline.
We found protective HLA alleles to be evenly distributed between individuals whose viruses 
developed escape mutations and those who did not (p=0.5, Fisher's exact test), and 
participants with protective HLA alleles had slower CD4+ decline. Interestingly, the 
association between HLA-associated escape mutations and CD4+ decline was robust to the 
exclusion of participants with protective HLA alleles. These data suggest that protective 
HLA alleles were not a major driver of the observed impact of HLA-associated escape 
mutations on CD4+ decline. Interestingly, while viral load is also correlated with CD4+ 
decline, the emergence of HLA-associated escape mutations in the first year of infection was 
not associated with plasma viral load, suggesting that CTL escape, independent of other 
disease progression makers, can predict CD4+ decline.
In this study, we have assessed the impact of HLA-associated escape mutations in the first 
year on CD4+ decline in the first five years of infection and showed that putative HLA-
associated escape mutations are associated with a shorter time to CD4+ decline to <350 
cells/μl, which is more pronounced in the variable Gag regions (p17 and p7p6) compared to 
the conserved p24. The high frequency of early putative escape may be a contributing factor 
disease progression in HIV-infected South Africans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Panel A) Association between number of HLA-associated escape sites and observed HLA-
associated escape mutations in Gag. Panel B) Relationship between number of HLA-
associated escape sites and log10 plasma viral load at 12 months post-infection. Panel C) 
Frequency of putative CTL escape at HLA-associated escape sites in the first year of 
infection in Gag, p17, p24 and p7p6. Panel D) Number of escape mutations per Gag protein 
normalised to protein size.
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Panel A) Association between HLA-associated escape mutations and CD4+ decline to <350 
cells/μl. Panel B) Association between no escape, HLA-associated escape mutations in 
conserved (p24) and in variable (p17 and p7p6) Gag proteins, and CD4+ decline to <350 
cells/μl.
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Panel A) Distribution of protective HLA alleles (HLA B*57, B*58:01 and B*81) between 
the two groups (escape and no escape). Panel B) Association between protective HLA 
alleles and CD4+ decline to <350 cells/μl. Panel C) Association between HLA-associated 
escape mutations and CD4+ decline to <350 cells/μl in individuals with non-protective HLA 
alleles. Panel D) Association between no escape, HLA-associated escape mutations in 
conserved (p24) and in variable (p17 and p7p6) Gag proteins, and CD4+ decline to <350 
cells/μl in individuals with non-protective HLA alleles.
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